RxDoctor Payments Data

Megan Davis

Family · Woodbury, TNNPI 1689191470

Payments from drug & device makers

$2,725in general payments, 2019–2025

Across 152 payments — averaging $17.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$506
  • Novo Nordisk$486
  • Corcept Therapeutics$288
  • Takeda Pharmaceuticals U.S.A., Inc.$198
  • Pfizer$192
  • Lilly USA, LLC$184
  • plus $871 from 21 others

What the payments were for

  • Food & beverage$2,725100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,725 in reported general payments places this provider in the 80th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide64$94,245
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$42,703
MounjaroTirzepatide33$40,852
FarxigaDapagliflozin Propanediol34$39,919
RybelsusSemaglutide23$36,228
JardianceEmpagliflozin34$31,376
GemtesaVibegron32$28,840
Breztri AerosphereBudesonide/Glycopyr/Formoterol31$25,189
EliquisApixaban21$16,770
BelsomraSuvorexant19$8,005
MyrbetriqMirabegron16$6,830
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$6,637
Advair HfaFluticasone Propion/Salmeterol11$5,712
Solifenacin Succinate17$3,856
Atorvastatin Calcium264$3,077

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$486$130,47387 claims
AstraZenecaFarxiga, Breztri Aerosphere$159$65,10865 claims
GSKTrelegy Ellipta, Anoro Ellipta$62$49,34069 claims
Lilly USA, LLCMounjaro$184$40,85233 claims
Sumitomo Pharma America, Inc.Gemtesa$84$28,84032 claims
PfizerEliquis$192$16,77021 claims
MerckBelsomra$17$8,00519 claims
Astellas Pharma US IncMyrbetriq$88$6,83016 claims
AbbVieSynthroid$506$1,61923 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,706 family providers in Tennessee.

Other family in Woodbury

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →